End-of-day quote
Shanghai S.E.
06:00:00 2024-07-15 pm EDT
|
5-day change
|
1st Jan Change
|
21.48
CNY
|
-0.56%
|
|
+0.99%
|
-12.33%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,045
|
13,491
|
11,564
|
10,059
|
6,477
|
5,721
|
-
|
-
|
Enterprise Value (EV)
1 |
3,045
|
13,491
|
11,564
|
10,059
|
6,477
|
5,721
|
5,721
|
5,721
|
P/E ratio
|
19.6
x
|
5
x
|
19.5
x
|
13.3
x
|
33.1
x
|
13.8
x
|
11
x
|
8.89
x
|
Yield
|
-
|
3.68%
|
1.17%
|
1.97%
|
2.04%
|
3.63%
|
2.28%
|
2.93%
|
Capitalization / Revenue
|
-
|
1.3
x
|
2.27
x
|
1.64
x
|
1.57
x
|
1.25
x
|
1.06
x
|
0.9
x
|
EV / Revenue
|
-
|
1.3
x
|
2.27
x
|
1.64
x
|
1.57
x
|
1.25
x
|
1.06
x
|
0.9
x
|
EV / EBITDA
|
-
|
-
|
-
|
10.1
x
|
-
|
7.86
x
|
6.44
x
|
5.45
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-48.1
x
|
26.4
x
|
34.7
x
|
33.5
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-2.08%
|
3.79%
|
2.88%
|
2.99%
|
Price to Book
|
-
|
3.4
x
|
2.84
x
|
1.63
x
|
1.22
x
|
1.02
x
|
0.96
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
196,000
|
215,748
|
225,105
|
264,351
|
264,351
|
266,322
|
-
|
-
|
Reference price
2 |
15.54
|
62.53
|
51.37
|
38.05
|
24.50
|
21.48
|
21.48
|
21.48
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
10,399
|
5,092
|
6,138
|
4,127
|
4,595
|
5,422
|
6,356
|
EBITDA
1 |
-
|
-
|
-
|
999.2
|
-
|
728
|
888
|
1,050
|
EBIT
1 |
-
|
3,537
|
822
|
812.8
|
225.9
|
495
|
621.5
|
784
|
Operating Margin
|
-
|
34.01%
|
16.14%
|
13.24%
|
5.47%
|
10.77%
|
11.46%
|
12.33%
|
Earnings before Tax (EBT)
1 |
-
|
3,533
|
819.9
|
801.7
|
218.9
|
491.5
|
617
|
780
|
Net income
1 |
156.9
|
2,549
|
595.9
|
681.1
|
198.4
|
414.2
|
520.3
|
644.7
|
Net margin
|
-
|
24.52%
|
11.7%
|
11.1%
|
4.81%
|
9.02%
|
9.6%
|
10.14%
|
EPS
2 |
0.7929
|
12.50
|
2.630
|
2.870
|
0.7400
|
1.560
|
1.955
|
2.415
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-134.5
|
216.7
|
164.8
|
170.8
|
FCF margin
|
-
|
-
|
-
|
-
|
-3.26%
|
4.72%
|
3.04%
|
2.69%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
29.77%
|
18.56%
|
16.26%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
52.32%
|
31.67%
|
26.49%
|
Dividend per Share
2 |
-
|
2.300
|
0.6000
|
0.7500
|
0.5000
|
0.7800
|
0.4900
|
0.6300
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-135
|
217
|
165
|
171
|
ROE (net income / shareholders' equity)
|
-
|
94.9%
|
16.2%
|
14.2%
|
3.6%
|
7.35%
|
8.7%
|
10.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
9.51%
|
-
|
5.3%
|
6.3%
|
7.1%
|
Assets
1 |
-
|
-
|
-
|
7,159
|
-
|
7,816
|
8,258
|
9,081
|
Book Value Per Share
2 |
-
|
18.40
|
18.10
|
23.40
|
20.10
|
21.10
|
22.50
|
24.10
|
Cash Flow per Share
|
-
|
13.70
|
-
|
5.250
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
1,093
|
689
|
745
|
587
|
535
|
468
|
509
|
Capex / Sales
|
-
|
10.51%
|
13.53%
|
12.13%
|
14.21%
|
11.63%
|
8.62%
|
8.01%
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Last Close Price
21.48
CNY Average target price
25
CNY Spread / Average Target +16.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.33% | 793M | | +11.58% | 28.56B | | +25.51% | 2.57B | | +25.93% | 2.53B | | -48.23% | 2.32B | | +34.44% | 2.09B | | -31.81% | 2.06B | | -23.71% | 1.6B | | +13.16% | 1.45B | | +31.35% | 1.33B |
Medical Supplies
|